多发性硬化症中二次进展风险的预测因素
Sini Laaksonen1,2,3,4, Marcus Sucksdorff5,2,3,4, Anna Vuorimaa5,2,3,4
1Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku 20521, Finland.
Therapeutic advances in neurological disorders
|September 15, 2025
概括
像TSPO结合和GFAP这样的生物标志物可以识别患有复发性硬化症 (MS) 的患者,这些患者有从复发性复发性硬化症 (RRMS) 发展到二次进展性硬化症 (SPMS) 的风险. 早期识别有助于及时治疗神经炎症.
科学领域:
- 神经免疫学 神经免疫学
- 神经成像是一种神经成像.
- 生物标志物发现发现
背景情况:
- 多发性硬化症 (MS) 呈现出不同的临床表型,包括复发性复发性硬化症 (RRMS) 和继发性进展性硬化症 (SPMS).
- 虽然适应性免疫驱动复发,但大脑中的先天性免疫激活有助于MS进展.
- 确定RRMS转化为SPMS的生物标志物对于有效的治疗策略至关重要.
研究的目的:
- 评估成像和血清生物标志物的预测价值,用于从RRMS到SPMS的临床过渡.
- 探索神经炎症标志物在预测MS疾病进展中的作用.
主要方法:
- 一项前性纵向研究跟踪了23名RRMS患者 (40-50岁) 5年.
- 评估的是临床状态,大脑MRI,血清GFAP和NfL,以及TSPO结合的[11C](R) - PK11195 PET.
- 转换为SPMS是由增加的残疾 (EDSS) 和临床症状积累来定义的.
主要成果:
- 35%的患者在5年内转换为SPMS.
- SPMS转换器显示出更高的TSPO结合基线在正常出现的白质,质和周围区域.
- 在SPMS转换器中观察到增加的TSPO阳性病变,更高的GFAP水平和更大的乳头缩.
结论:
- 反映中枢神经系统炎症的成像和血清生物标志物可以识别有SPMS转化风险的MS患者.
- 甲状腺缩和可溶性生物标志物 (GFAP) 可以整合到临床实践中,以评估进展风险.
- 这种方法可能有助于针对MS病理的向疗法,尽管需要进行更大的验证研究.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Psychological and Sociocultural Causes of Schizophrenia
481
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
481


